Synthesis and Antiproliferative Ativity of 2,4-Bis(indol-3-yl)pyrrole Derivatives: Marine Nortopsentin Analogs | ||||
Egyptian Journal of Chemistry | ||||
Article 67, Volume 64, Issue 8, August 2021, Page 4697-4706 PDF (669.98 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ejchem.2021.84060.4117 | ||||
View on SCiNiTO | ||||
Authors | ||||
Mohamed Rdwan 1; Osama alrugaie2; Waleed Al Abdulmonem3; Mohammad Alfaifi4; Serag Eldin Elbehairi5 | ||||
1Department of Applied Organic Chemistry, National Research Center, Dokki 12622, Egypt | ||||
2Department of Basic Medical Sciences, Unaizah College of Medicine and Medical Sciences, Qassim University, Unaizah, Saudi Arabia | ||||
3Department of Pathology, College of Medicine, Qassim University, Buraidah, Saudi Arabia. (dr.waleedmonem@qu.edu.sa) | ||||
4King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia | ||||
5Cell Culture Lab, Egyptian Organization for Biological Products and Vaccines (VACSERA Holding Company), 51 Wezaret El-Zeraa St., Agouza, Giza, Egypt | ||||
Abstract | ||||
Abstract In this study, a series of nortopsentin analogs (2,4-bis(indol-3-yl)pyrrole derivatives) were designed, synthesized, and tested for their in vitro cytotoxic activity against three cell lines: human prostate adenocarcinoma (PC-3), human ovary adenocarcinoma (SKOV3), and human Dukes' type B colorectal adenocarcinoma (LS-174T). Compounds 5a, 5e, 5h, 5j, and 5k had stronger antiproliferative activity against SKOV3, compound 5h and 5b against LS-174T, and compound 5e against PC-3 than the known doxorubicin drug. As a result, this work provides the framework for further research into 2,4-bis(indol-3-yl)pyrrole derivatives as antiproliferative drugs. | ||||
Keywords | ||||
Indole; bisindole; nortopsentin; pyrrole; antiproliferative | ||||
Statistics Article View: 282 PDF Download: 317 |
||||